Global Monoclonal Antibodies Market Growth 2023-2029

Global Monoclonal Antibodies Market Growth 2023-2029

Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.

LPI (LP Information)' newest research report, the “Monoclonal Antibodies Industry Forecast” looks at past sales and reviews total world Monoclonal Antibodies sales in 2022, providing a comprehensive analysis by region and market sector of projected Monoclonal Antibodies sales for 2023 through 2029. With Monoclonal Antibodies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monoclonal Antibodies industry.

This Insight Report provides a comprehensive analysis of the global Monoclonal Antibodies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monoclonal Antibodies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Monoclonal Antibodies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monoclonal Antibodies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monoclonal Antibodies.

The global Monoclonal Antibodies market size is projected to grow from US$ 103490 million in 2022 to US$ 142030 million in 2029; it is expected to grow at a CAGR of 142030 from 2023 to 2029.

This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.

This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibodies market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Erythropoietin (EPO)
Human Growth Hormone (HGH)
Granulocyte- Colony Stimulating Factor (G-CSF)
Monoclonal Antibody (mAb)
Insulin
Interferon (IFN)
Others

Segmentation by application
Anti-Cancer
Anti-Inflammatory/Autoimmune

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biocon
Celltrion
Dr. Reddy's Laboratories
Hospira
3SBio
Accord Healthcare
AET Biotech
Allergan
Amega Biotech

Key Questions Addressed in this Report

What is the 10-year outlook for the global Monoclonal Antibodies market?

What factors are driving Monoclonal Antibodies market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Monoclonal Antibodies market opportunities vary by end market size?

How does Monoclonal Antibodies break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.